The American Medical Association today adopted a policy declaring drug shortages an urgent public health crisis. As part of the policy, AMA will urge the Department of Health and Human Services and the Department of Homeland Security to examine drug shortages as a national security initiative, and call for greater manufacturer transparency regarding production location and problems and more information on the quality of outsourcing compounding facilities. The policy supports recommendations issued last year by the American Society of Healthy-System Pharmacists, AHA and other organizations as part of a drug shortages roundtable.   

Related News Articles

Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…